Search
for
Sort by
Research 631–660 of 1000+
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Associaton of Insulin Resistance Linked Diseases and Hair Loss in Elderly Men. Finnish Population-based Study
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Association of premature hair graying with family history, smoking, and obesity: A cross-sectional study
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- A Clinical Approach to Severe Insulin Resistance
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
- Sun-protection behaviors of melanoma survivors
- Cross-sex hormone therapy for gender dysphoria
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data
- Assessment, diagnosis and treatment of a patient with hirsutism
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Case 21-2012
- Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
- Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age
- Skin diseases in consequence of endocrine alterations
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?